Article Versions Notes

Haggenburg S, Garcia Garrido HM, Kant IMJ, Van der Straaten HM, De Boer F, Kersting S, Issa D, Te Raa D, Visser HPJ, Kater AP, et al. Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia. Vaccines. 2023; 11(7):1201. https://doi.org/10.3390/vaccines11071201

Haggenburg, Sabine, Hannah M. Garcia Garrido, Iris M. J. Kant, Hanneke M. Van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein P. J. Visser, Arnon P. Kater, and et al. 2023. "Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia" Vaccines 11, no. 7: 1201. https://doi.org/10.3390/vaccines11071201

Haggenburg, S., Garcia Garrido, H. M., Kant, I. M. J., Van der Straaten, H. M., De Boer, F., Kersting, S., Issa, D., Te Raa, D., Visser, H. P. J., Kater, A. P., Goorhuis, A., & De Heer, K. (2023). Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia. Vaccines, 11(7), 1201. https://doi.org/10.3390/vaccines11071201